Summary Summary Short summary of a recent publication, written by scientific experts.

Association of CSF and MRI markers with atrophy in multiple sclerosis

Takeaway

  • Neurofilament light chain (NfL) and chitinase 3-like protein 1 (CHI3L1) in the cerebrospinal fluid (CSF) were differentially related to the atrophy of the brain and spinal cord.

Why this matters

  • Brain and spinal cord atrophy are established paraclinical markers of disease progression and are associated with axonal degeneration and demyelination in MS.

    • With the advent of immune therapies in MS, the results from this study may suggest that CSF levels of CHI3L1 and NfL can reliably predict disease activity and treatment response.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.

Learn more

Imaging Multiple Sclerosis CSF MRI Brain atrophy Biomarkers Spinal cord atrophy